Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Hamilton Thorne Ltd. (T:HTL)

Business Focus: Advanced Medical Equipment & Technology (NEC)

INK Edge Outlook

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for HTL within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 27, 2024 08:45 ET
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited...
Read full article
Mar 21, 2024 15:00 ET
Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024
Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.32
--
--
Price to Sales - TTM
2.23
11.19
3.46
Price to Book - most recent quarter
2.48
2.66
2.02
Price to Cash Flow per share - TTM
36.73
9.43
9.70
Price to Free Cash Flow per share - TTM
--
--
12.33
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 202445,74243,178
Feb 29, 20242,564-3,095
Feb 15, 20245,6593,774
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.

See business summary

 

Twitter

Search (past week) for $HTL.CA

  • No tweets found